Functional outcomes of sustained improvement on Diabetic Retinopathy Severity Scale with intravitreal aflibercept in the VISTA and VIVID trials.

Dhoot, Dilsher S; Moini, Hadi; Reed, Kimberly; Du, Weiming; Vitti, Robert; Berliner, Alyson J; Singh, Rishi P

Dhoot, Dilsher S; Moini, Hadi; Reed, Kimberly; Du, Weiming; Vitti, Robert; Berliner, Alyson J; Singh, Rishi P.

Affiliation

Dhoot DS; California Retina Consultants/Retina Consultants of America, Santa Barbara, CA, USA.
Moini H; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Reed K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Du W; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Vitti R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Berliner AJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Singh RP; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA. drrishisingh@gmail.com.

Eye (Lond) ; 37(10): 2020-2025, 2023 07.

Article in En | MEDLINE | ID: mdl-35440699

Subject(s)

Diabetes Mellitus; Diabetic Retinopathy; Macular Edema; Humans; Angiogenesis Inhibitors/therapeutic use; Diabetic Retinopathy/diagnosis; Diabetic Retinopathy/drug therapy; Diabetic Retinopathy/surgery; Intravitreal Injections; Laser Coagulation/adverse effects; Macular Edema/diagnosis; Macular Edema/drug therapy; Macular Edema/surgery; Receptors, Vascular Endothelial Growth Factor/therapeutic use; Recombinant Fusion Proteins/therapeutic use; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A/therapeutic use; Clinical Trials as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Macular Edema / Diabetes Mellitus / Diabetic Retinopathy Limits: Humans Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2023 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google